This report presents the results of the first external quality assurance (EQA) scheme for B. pertussis antimicrobial susceptibility testing by ECDC as part of the European Reference Laboratory Network for Pertussis (ERLNPert-Net) consortium.
This report presents the results of the first external quality assessment (EQA) scheme for Bordetella pertussis vaccine antigen expression, pertactin (PRN), pertussis toxin (PT) and filamentous haemagglutinin (FHA) by the European Centre for Disease Prevention and Control (ECDC) as part of the European Reference Laboratory Network for Pertussis (ERLNPert-Net) activities.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 April 2023 and includes updates on cholera, avian influenza, COVID-19, invasive meningococcal disease, influenza, Marburg virus disease, and the seizure of a reference laboratory by an armed group.
This literature review, covering the period from 2000 to January 2022, assessed the state of knowledge on biocide resistance in wild vector populations across the EU/EEA and neighbouring countries.
Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.